Glucagon-like peptide-1 cleavage product GLP-1 (9-36) amide enhances hippocampal long-term synaptic plasticity in correlation with suppression of Kv4.2 expression and eEF2 phosphorylation. Day SM, Yang W, Ewin S, Zhou X, Ma T.. Hippocampus. 2017;():.
Impaired eukaryotic elongation factor 1A expression in Alzheimer's disease. Beckelman BC, Zhou X, Keene CD, Ma T.. Neurodegener Dis. 2016;16(1-2):39-43.
Repression of the eIF2alpha kinase PERK alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease. Yang W, Zhou X, Zimmermann HR, Cavener DR, Klann E, Ma T.. Neurobiol Aging. 2016;41():19-24.
Dysregulation of elongation factor 1A expression is correlated with synaptic plasticity impairments in Alzheimer's disease. Beckelman BC, Day S, Zhou X, Donohue M, Gouras GK, Klann E, Keene CD, Ma T.. J Alzheimers Dis. 2016;54(2):669-678.
Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid beta. Ma T, Chen Y, Vingtdeux V, Zhao H, Viollet B, Marambaud P, Klann E.. J Neurosci. 2014;34(36):12230-38.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.